Isofol Medical

0,67 SEK

-0,74%

Mindre end 1K følgere

ISOFOL

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Isofol Medical

EV/S

Medianen 2020-2023

EV/EBIT

Medianen 2019-2025

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)10,0819,458,120,650,641,950,73
Aktier64,5120,0183,8183,8183,8183,8281,1
Markedsværdi650,22.334,21.492,4119,5117,9358,6204,9
Enterprise value526,02.219,31.114,6-68,6-20,2265,477,9
EV/S-59,849,7neg.neg.--
EV/EBITDAneg.neg.neg.0,40,5neg.neg.
EV/EBITneg.neg.neg.0,40,5neg.neg.
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B6,2035,074,690,750,974,601,90
P/S-62,966,69,3163,8--
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio71,6 %44,9 %79,3 %74,2 %86,4 %79,2 %83,4 %
Gearing ratio2,6 %2,2 %0,5 %1,5 %---